Page last updated: 2024-11-03

procainamide and Kidney Failure, Chronic

procainamide has been researched along with Kidney Failure, Chronic in 22 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research Excerpts

ExcerptRelevanceReference
"Fractional hydrolysis and acetylation of procainamide, acetylation of procainamide-derived p-aminobenzoic acid and plasma hydrolysis of procaine were studied in 20 patients with chronic heart failure (CHF), 20 patients with chronic respiratory insufficiency (CRI) and 20 patients with chronic renal failure (RF)."7.66Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure. ( du Souich, P; Erill, S, 1978)
"A patient with chronic renal failure who experienced symptomatic ventricular tachycardia was treated successfully with procainamide (PA) after numerous dosage adjustments to optimize his clinical response and serum PA and NAPA concentrations."3.66High-dose procainamide in chronic renal failure. ( Batenhorst, RL; Bottorff, MB; Kuo, CS, 1983)
"Two patients with chronic renal failure developed transient sinus node dysfunction requiring insertion of a temporary pacemaker while receiving procainamide to control ventricular arrhythmias."3.66Procainamide-induced sinus node dysfunction in patients with chronic renal failure. ( Friedman, HS; Kim, HG, 1979)
"Fractional hydrolysis and acetylation of procainamide, acetylation of procainamide-derived p-aminobenzoic acid and plasma hydrolysis of procaine were studied in 20 patients with chronic heart failure (CHF), 20 patients with chronic respiratory insufficiency (CRI) and 20 patients with chronic renal failure (RF)."3.66Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure. ( du Souich, P; Erill, S, 1978)
"A 66-year-old female with chronic renal failure received five doses of procainamide and developed marked QT interval prolongation and recurrent episodes of torsades de pointes, which were temporally related to high serum n-acetylprocainamide (NAPA) levels and not to procainamide levels."1.27Torsades de pointes due to n-acetylprocainamide. ( Stevenson, WG; Weiss, J, 1985)
" The procainamide elimination half-life ranged from 6."1.27Procainamide pharmacokinetics in patients on continuous ambulatory peritoneal dialysis. ( Beirne, GJ; Moorthy, AV; Raehl, CL, 1986)
"Procainamide was assayed by spectrophotometry and spectrophotofluorometry."1.25Elimination of procainamide in end stage renal failure. ( Briggs, WA; Gibson, TP; Lowenthal, DT; Nelson, HA, 1975)

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-199022 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raja, R1
Kramer, M1
Alvis, R1
Goldstein, S1
DeLosAngeles, A1
Basseches, PJ1
DiGregorio, GJ1
Ochotny, R1
MichaƂowska, D1
Lowicki, Z1
Chmara, E1
Bottorff, MB1
Kuo, CS1
Batenhorst, RL1
Mathui, N1
Nakagawa, S1
Takeuchi, J1
Stec, GP1
Atkinson, AJ2
Nevin, MJ1
Thenot, JP1
Ruo, TI1
Gibson, TP4
Ivanovich, P1
del Greco, F1
Kim, HG1
Friedman, HS1
Nattel, S1
Ogilvie, RI1
Kreeft, J1
Sitar, DS1
Graham, DN1
Rangno, RE1
Dufresne, LR1
Barre, PE1
Dhingra, RC1
Rosen, KM1
Reidenberg, MM2
Drayer, DE3
Matusik, E1
Nelson, LD1
Briggs, WA3
du Souich, P1
Erill, S1
Lowenthal, DT3
Woosley, RL1
Nies, AS1
Schwartz, A1
Nelson, HA1
Shapiro, B1
Kollmann, GJ1
Heine, WI1
Matusik, EJ1
Stevenson, WG1
Weiss, J1
Braden, GL1
Fitzgibbons, JP1
Germain, MJ1
Ledewitz, HM1
Raehl, CL1
Moorthy, AV1
Beirne, GJ1
Sica, DA1
Yonce, C1
Small, R1
Cefali, E1
Harford, A1
Poynor, W1

Other Studies

22 other studies available for procainamide and Kidney Failure, Chronic

ArticleYear
Resin hemoperfusion for severe N-acetylprocainamide toxicity in patients with renal failure.
    Transactions - American Society for Artificial Internal Organs, 1984, Volume: 30

    Topics: Acecainide; Aged; Arrhythmias, Cardiac; Female; Hemoperfusion; Humans; Kidney Failure, Chronic; Male

1984
Excretion of procainamide into bile and saliva in rats with chronic renal failure.
    Archives internationales de pharmacodynamie et de therapie, 1982, Volume: 257, Issue:2

    Topics: Acecainide; Animals; Bile; Kidney Failure, Chronic; Male; Procainamide; Rats; Rats, Inbred Strains;

1982
[Procainamide in renal failure].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1983, Oct-10, Volume: 38, Issue:41

    Topics: Adult; Female; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Procainamide

1983
High-dose procainamide in chronic renal failure.
    Drug intelligence & clinical pharmacy, 1983, Volume: 17, Issue:4

    Topics: Adult; Humans; Kidney Failure, Chronic; Male; Procainamide; Tachycardia

1983
[Procainamide-induced bleeding tendencies in hemodialysis patients (author's transl)].
    Nihon Jinzo Gakkai shi, 1982, Volume: 24, Issue:2

    Topics: Adult; Blood Platelet Disorders; Humans; Iatrogenic Disease; Kidney Failure, Chronic; Male; Middle A

1982
N-Acetylprocainamide pharmacokinetics in functionally anephric patients before and after perturbation by hemodialysis.
    Clinical pharmacology and therapeutics, 1979, Volume: 26, Issue:5

    Topics: Acecainide; Adult; Computers; Female; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged;

1979
Procainamide-induced sinus node dysfunction in patients with chronic renal failure.
    Chest, 1979, Volume: 76, Issue:6

    Topics: Acecainide; Aged; Angina Pectoris; Arrhythmia, Sinus; Arrhythmias, Cardiac; Bradycardia; Female; Hea

1979
Procainamide acetylation and disposition in dialysis patients.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1979, Volume: 2, Issue:1

    Topics: Acetylation; Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Biological Availability; Femal

1979
Procainamide and the sinus node.
    Chest, 1979, Volume: 76, Issue:6

    Topics: Aged; Arrhythmia, Sinus; Humans; Kidney Failure, Chronic; Lidocaine; Procainamide; Sinoatrial Node

1979
Drug metabolism and active drug metabolites in renal failure.
    Journal of dialysis, 1977, Volume: 1, Issue:4

    Topics: Allopurinol; Biotransformation; Clofibrate; Dose-Response Relationship, Drug; Humans; Kidney Failure

1977
Kinetics of procainamide and N-acetylprocainamide in renal failure.
    Kidney international, 1977, Volume: 12, Issue:6

    Topics: Adult; Female; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Male; Metabolic Clearance Rate;

1977
Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure.
    European journal of clinical pharmacology, 1978, Nov-09, Volume: 14, Issue:1

    Topics: Acetylation; Adult; Aged; Chronic Disease; Female; Half-Life; Heart Failure; Humans; Hydrolysis; Kid

1978
Active drug metabolites and renal failure.
    The American journal of medicine, 1977, Volume: 62, Issue:4

    Topics: Acetylation; Biotransformation; Clofibrate; Humans; Kidney Failure, Chronic; Meperidine; Methyldopa;

1977
Pharmacokinetics of propranolol, quinidine, procainamide and lidocaine in chronic renal disease.
    The American journal of medicine, 1977, Volume: 62, Issue:4

    Topics: Biotransformation; Dose-Response Relationship, Drug; Humans; Kidney; Kidney Failure, Chronic; Lidoca

1977
Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function.
    Clinical pharmacology and therapeutics, 1977, Volume: 22, Issue:1

    Topics: Acetylation; Aged; Arrhythmias, Cardiac; Humans; Kidney Failure, Chronic; Male; Middle Aged; Procain

1977
Elimination of procainamide in end stage renal failure.
    Clinical pharmacology and therapeutics, 1975, Volume: 17, Issue:3

    Topics: Acetylation; Female; Half-Life; Humans; Kidney Failure, Chronic; Male; Procainamide; Renal Dialysis;

1975
Pitfalls in the application of digoxin determinations.
    Seminars in nuclear medicine, 1975, Volume: 5, Issue:3

    Topics: Administration, Oral; Aged; Biopharmaceutics; Calcium; Digoxin; Drug Interactions; Female; Heart Dis

1975
N-Acetylprocainamide levels in patients with end-stage renal failure.
    Clinical pharmacology and therapeutics, 1976, Volume: 19, Issue:2

    Topics: Acetylation; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Metabolic Clearance Rate; Procain

1976
Torsades de pointes due to n-acetylprocainamide.
    Pacing and clinical electrophysiology : PACE, 1985, Volume: 8, Issue:4

    Topics: Acecainide; Aged; Female; Humans; Kidney Failure, Chronic; Procainamide; Renal Dialysis; Tachycardia

1985
Hemoperfusion for treatment of N-acetylprocainamide intoxication.
    Annals of internal medicine, 1986, Volume: 105, Issue:1

    Topics: Acecainide; Hemoperfusion; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Procainamid

1986
Procainamide pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
    Nephron, 1986, Volume: 44, Issue:3

    Topics: Acecainide; Adult; Aged; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Pe

1986
Pharmacokinetics of procainamide in continuous ambulatory peritoneal dialysis.
    International journal of clinical pharmacology, therapy, and toxicology, 1988, Volume: 26, Issue:2

    Topics: Acecainide; Adult; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis,

1988